Level B· Emerging clinical evidence with positive signalsRandomized Controlled TrialPubMedOpen access

Comparison of the Effects of Adipose Extracellular Matrix/Stromal Vascular Fraction Gel Injection and CO 2 Fractional Laser on Atrophic Acne Scar in Asians Through a 24-Week Prospective, Randomized, Split-Face Study.

Zhao T., Li M., Wang J., Liu J., Wei J., Liu X.

Randomized Controlled Trial with a reported sample of 11 on Scar, published in J Cosmet Dermatol (2025) — summary generated from the PubMed abstract.

Open my reading list
Level B· Emerging clinical evidence with positive signalsEvidence level of this study

Several human studies show positive signals, while research methods and sample sizes continue to develop.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Randomized Controlled Trial
Journal
J Cosmet Dermatol (2025)
Country
England
Reported sample size
11
Source database
PubMed
PMID
40112029
PMCID
PMC11925327
DOI
10.1111/jocd.70131
NCT
NCT06116162
Citations
1

Abstract (original English)

Adipose extracellular matrix/stromal vascular fraction gel (ECM/SVF-gel) contains adipose-derived stem cells, extracellular matrix, and other cell components, and possesses the ability to promote collagen production and serve as a filling agent. To assess the efficacy and safety of ECM/SVF-gel injection for the treatment of acne scars, compared to CO 2 fractional laser (CO 2 FL). We performed an open-label, investigator-initiated, assessor-blinded, split-face trial in Xijing Hospital, China, between July 11, 2020, and December 30, 2022. Patients exhibiting moderate to severe acne scars were randomly assigned to a single ECM/SVF-gel injection on one half of the face or two sessions of CO 2 FL treatments on the other half. The primary outcome was the change in total Echelle d'Evaluation Clinique des Cicatrices d'acne (ECCA) score from baseline to 24-week follow-up. Secondary outcomes included the changes in the volume of scars assessed by the Antera 3D software. A total of 11 participants were enrolled, and 10 completed the follow-up. The mean age of patients was 27.5 ± 4.2, 7 female and four male, seven with Fitzpatrick skin Type III and four with Type IV. At 24weeks, the mean change in ECCA score was -60.25 on the side of ECM/SVF-gel injection and - 43.25 on the side of CO 2 FL treatment (difference:-17.00 [95% CI: -24.56 to -9.44], p < 0.001). Antera 3D photography analysis sh

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Several human studies show positive signals, while research methods and sample sizes continue to develop.

How we grade evidence
HumansFemaleAcne VulgarisAdultCicatrixMaleLasers, GasGelsProspective StudiesExtracellular Matrix

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research